In animal studies, the use of metformin was linked to a decrease in AAA formation and progression, alongside the preservation of medial elastin and aortic SMCs, a reduction in the accumulation of immune cells, and decreased levels of neovascularization [10,11]. The gene discussed is ELN; the disease is triple-A syndrome.